ADIL, ANNX and MINM are among pre market gainers

seekingalpha03-01

Gainers: BioVie (BIVI) +152% Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2416645304?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","is_english":true,"pubTime":"2024-03-01 21:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2416645304","market":"nz","top_or_hot":-1,"title":"ADIL, ANNX and MINM are among pre market gainers","media":"seekingalpha","content":"<div>\n<p>Gainers: BioVie (BIVI) +152% Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients...</p>\n\n<a href=\"https://seekingalpha.com/news/4074539-adil-annx-and-minm-are-among-pre-market-gainers\">Source Link</a>\n\n</div>\n","source":"seekingalpha_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ADIL, ANNX and MINM are among pre market gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nADIL, ANNX and MINM are among pre market gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-01 21:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4074539-adil-annx-and-minm-are-among-pre-market-gainers><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers: BioVie (BIVI) +152% Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients...</p>\n\n<a href=\"https://seekingalpha.com/news/4074539-adil-annx-and-minm-are-among-pre-market-gainers\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADIL","symbol_name":"Adial Pharmaceuticals","start_time":0,"source_url":"https://seekingalpha.com/news/4074539-adil-annx-and-minm-are-among-pre-market-gainers","article_id":"2416645304","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2416645304","pubTimestamp":1709300929,"columns":[],"sourceInfo":{"source_id":"seekingalpha_hot_news","name":"SeekingAlpha"},"weMediaInfo":null,"summary":"Gainers: BioVie (BIVI) +152% Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ADIL":"Adial Pharmaceuticals","EVBG":"Everbridge Inc.","BK7045":"广告","CTV":"Innovid","LU0323240290.USD":"HSBC GIF GLOBAL EQUITY CLIMATE CHANGE \"AD\" INC","BDRX":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD","UNCY":"Unicycive Therapeutics, Inc.","BBLG":"Bone Biologics Corp","NVTS":"纳微半导体","BK4554":"元宇宙及AR概念","OCEA":"Ocean Biomedical","BK4515":"5G概念","NTAP":"美国网存","SG":"Sweetgreen, Inc.","BIVI":"BioVie Inc","BK4585":"ETF&股票定投概念","SYRA":"Syra Health Corp.","BK4507":"流媒体概念","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","DELL":"戴尔","TDCX":"TDCX Inc.","BK4007":"制药","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","BK4566":"资本集团","LU1992135399.USD":"Allianz Global Intelligent Cities AT Acc USD","ADSK":"欧特克","BK4009":"广告","BK4196":"保健护理服务","REAL":"The RealReal","JL":"即亮集团","ENVB":"Enveric Biosciences","BK4535":"淡马锡持仓","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","BK4020":"通信设备","BK4077":"互动媒体与服务","OPRA":"欧朋公司","BK4141":"半导体产品","MTC":"海川证券","BK7095":"多种金属与采矿","BK4122":"互联网与直销零售","CTV.AU":"ColorTV Ltd","BK4094":"服装零售","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","FUBO":"fuboTV Inc.","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","MINM":"Minim Inc.","CRDF":"Cardiff Oncology, Inc.","ANNX":"Annexon, Inc.","MTC.AU":"METALSTECH LTD","AMRX":"Amneal Pharmaceuticals, Inc."},"translate_title":"ADIL、ANNX和MINM都在盘前上涨之列","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MTC.AU":1,"CRDF":1,"CTV":1,"ADIL":1,"DELL":1,"ENVB":1,"EVBG":1,"FUBO":1,"JL":1,"MINM":1,"MTC":1,"CTV.AU":1,"NTAP":1,"NVTS":1,"OCEA":1,"OPRA":1,"REAL":1,"SG":1,"SYRA":1,"TDCX":1,"UNCY":1,"ADSK":1,"AMRX":1,"ANNX":1,"BBLG":1,"BDRX":1,"BIVI":1},"content_text":"Gainers: BioVie (BIVI) +152% Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024.  Bone Biologics (BBLG) +61% Reports Progress With NB1 Clinical Program.  Adial Pharmaceuticals (ADIL) +60%. Minim (MINM) +44%. Mmtec (MTC) +30%. Dell Technologies (DELL) +26% Q4 earnings call release  Everbridge (EVBG) +25% stock climbs as Thoma Bravo lifts buyout offer.  Sweetgreen (SG) +22% Q4 earnings call release  Therealreal (REAL) +20% Q4 earnings call reease  Netapp (NTAP) +19% Q3 earnings call release  J-Long Group (JL) +16%. Navitas Semiconductor (NVTS) +16% Q4 earnings call release  Cardiff Oncology (CRDF) +14% Q4 earnings call release  fuboTV (FUBO) +15%  New York Community Bancorp, Dell Technologies, and more.  TDCX (TDCX) +14% Enters into Definitive Merger Agreement for Going-Private Transaction.  Amneal Pharmaceuticals (AMRX) +12% Q4 earnings call release  Ocean Biomedical (OCEA) +11% Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting.  Opera (OPRA) +10% Q4 earnings call release  Annexon (ANNX) +10%. Biodexa Pharmaceuticals (BDRX) +8% Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone.  Syra Health (SYRA) +3%. Autodesk (ADSK) +9% Q4 earnings call release  Innovid (CTV) +9% Q4 earnings call release  Enveric Biosciences (ENVB) +8% passes bill to end hard drug decriminalization.  Unicycive Therapeutics (UNCY) +8%.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2416645304"}